Literature DB >> 2506602

Low doses of corticotropin-releasing factor potentiate amphetamine-induced stereotyped behavior.

B J Cole1, G F Koob.   

Abstract

Corticotropin-releasing factor (CRF) is a 41-amino acid polypeptide that is critically involved in the activation of the hypothalamic-pituitary adrenal axis during stress. In addition, it has been suggested that extrahypothalamic CRF may be important in initiating behavioral responses to stressful events. In the present experiment, we examined the effects of central administration of CRF on amphetamine-induced stereotyped behavior. Amphetamine-induced stereotyped behavior has been considered as a behavioral strategy to cope with excessive arousal. Low doses of CRF (0.02 and 0.1 micrograms), administered into the lateral ventricle (ICV), were shown to potentiate amphetamine (4.0 mg/kg; SC)-induced stereotyped behavior, as measured by the Creese and Iversen rating scale and behavioral observations. These low doses of CRF specifically enhanced the tendency for rats to sniff with their heads down 20 min after injection, and induced licking behavior later during testing. In contrast, the rats treated with a higher dose of CRF (0.5 micrograms, ICV) showed more locomotor activity throughout the test, but did not differ from the saline-treated animals in the intensity of amphetamine-induced stereotyped behavior.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506602     DOI: 10.1007/bf00634448

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  48 in total

1.  Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study.

Authors:  E B De Souza; T R Insel; M H Perrin; J Rivier; W W Vale; M J Kuhar
Journal:  J Neurosci       Date:  1985-12       Impact factor: 6.167

2.  Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems.

Authors:  A J Dunn; C W Berridge
Journal:  Pharmacol Biochem Behav       Date:  1987-08       Impact factor: 3.533

3.  Corticotropin-releasing factor and behavior.

Authors:  G F Koob; F E Bloom
Journal:  Fed Proc       Date:  1985-01

4.  Corticotropin releasing factor produces behavioural activation in rats.

Authors:  R E Sutton; G F Koob; M Le Moal; J Rivier; W Vale
Journal:  Nature       Date:  1982-05-27       Impact factor: 49.962

5.  Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats.

Authors:  L A Fisher; J Rivier; C Rivier; J Spiess; W Vale; M R Brown
Journal:  Endocrinology       Date:  1982-06       Impact factor: 4.736

6.  Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.

Authors:  I Creese; S D Iversen
Journal:  Brain Res       Date:  1973-06-15       Impact factor: 3.252

7.  The pharmacological and anatomical substrates of the amphetamine response in the rat.

Authors:  I Creese; S D Iversen
Journal:  Brain Res       Date:  1975-01-17       Impact factor: 3.252

8.  Effects of alpha-flupenthixol and naloxone on CRF-induced locomotor activation.

Authors:  G F Koob; N Swerdlow; M Seeligson; M Eaves; R Sutton; J Rivier; W Vale
Journal:  Neuroendocrinology       Date:  1984-11       Impact factor: 4.914

9.  Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study.

Authors:  L W Swanson; P E Sawchenko; J Rivier; W W Vale
Journal:  Neuroendocrinology       Date:  1983       Impact factor: 4.914

10.  Separate neural substrates of the locomotor-activating properties of amphetamine, heroin, caffeine and corticotropin releasing factor (CRF) in the rat.

Authors:  N R Swerdlow; G F Koob
Journal:  Pharmacol Biochem Behav       Date:  1985-08       Impact factor: 3.533

View more
  6 in total

1.  The development of sensitization to the psychomotor stimulant effects of amphetamine is enhanced in a novel environment.

Authors:  A Badiani; S G Anagnostaras; T E Robinson
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

Review 2.  A neuropeptide-centric view of psychostimulant addiction.

Authors:  B Boutrel
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

Review 3.  Stress, sex, and addiction: potential roles of corticotropin-releasing factor, oxytocin, and arginine-vasopressin.

Authors:  Verónica Bisagno; Jean Lud Cadet
Journal:  Behav Pharmacol       Date:  2014-09       Impact factor: 2.293

4.  Individual differences in sugar intake predict the locomotor response to acute and repeated amphetamine administration.

Authors:  T L Sills; F J Vaccarino
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530

5.  Methamphetamine causes differential alterations in gene expression and patterns of histone acetylation/hypoacetylation in the rat nucleus accumbens.

Authors:  Tracey A Martin; Subramaniam Jayanthi; Michael T McCoy; Christie Brannock; Bruce Ladenheim; Tiffany Garrett; Elin Lehrmann; Kevin G Becker; Jean Lud Cadet
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

6.  Learning and CRF-Induced Indecision during Escape and Submission in Rainbow Trout during Socially Aggressive Interactions in the Stress-Alternatives Model.

Authors:  Tangi R Summers; Torrie L Summers; Russ E Carpenter; Justin P Smith; Samuel L Young; Brandon Meyerink; T Zachary Orr; David H Arendt; Cliff H Summers
Journal:  Front Neurosci       Date:  2017-09-15       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.